E-LIB Suche - Ergebnisse für: Gulbis, Alison

1

P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONI..:

Popat, Uday R. ; Lontos, Konstantinos ; Bassett, Roland...
HemaSphere. 7 (2023) S3 - p. e069901e , 2023

Link: https://doi.org/10.1097/..

2

A randomized phase III study of pretransplant conditioning ..:

Andersson, Borje S. ; Thall, Peter F. ; Ma, Junsheng...
Bone Marrow Transplantation. 57 (2022) 8 - p. 1295-1303 , 2022

Link: https://doi.org/10.1038/..

3

Improved outcomes of high-risk relapsed Hodgkin lymphoma pa..:

Nieto, Yago ; Gruschkus, Stephen ; Valdez, Benigno C....
Haematologica. 107 (2021) 4 - p. 899-908 , 2021

Link: https://doi.org/10.3324/..

4

AML-314: Post-Transplant Cyclophosphamide Reduces the Incid..:

Saberian, Chantal ; Abdel-Wahab, Noha ; Abudayyeh, Ala...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S201-S202 , 2020

Link: https://doi.org/10.1016/..

5

List of Contributors:

, In: Hematopoietic Cell Transplantation for Malignant Conditions,

Ahmad, Mufti Naeem ; Ahmed, Sairah ; Arslan, Shukaib... - p. v-viii , 2019

Link: https://doi.org/10.1016/..

6

High-Dose Chemotherapy Regimens:

, In: Hematopoietic Cell Transplantation for Malignant Conditions,

Yan, Lily ; Gulbis, Alison - p. 37-57 , 2019

Link: https://doi.org/10.1016/..

7

Prevention of Cytomegalovirus Reactivation in Haploidentica..:

Hammerstrom, Aimee E. ; Lombardi, Lindsey R. ; Pingali, Sai Ravi...
Biology of Blood and Marrow Transplantation. 24 (2018) 2 - p. 353-358 , 2018

Link: https://doi.org/10.1016/..

8

Choosing Wisely BMT: American Society for Blood and Marrow ..:

Bhella, Sita ; Majhail, Navneet S. ; Betcher, Jeffrey...
Biology of Blood and Marrow Transplantation. 24 (2018) 5 - p. 909-913 , 2018

Link: https://doi.org/10.1016/..

9

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan ..:

Nieto, Yago ; Thall, Peter F. ; Ma, Junsheng...
Biology of Blood and Marrow Transplantation. 24 (2018) 8 - p. 1602-1609 , 2018

Link: https://doi.org/10.1016/..

10

Management guidelines for paediatric patients receiving chi..:

Mahadeo, Kris M. ; Khazal, Sajad J. ; Abdel-Azim, Hisham...
Nature Reviews Clinical Oncology. 16 (2018) 1 - p. 45-63 , 2018

Link: https://doi.org/10.1038/..

11

High-dose gemcitabine, busulfan, and melphalan for autologo..:

Nieto, Yago ; Valdez, Benigno C ; Pingali, Sai R...
The Lancet Haematology. 4 (2017) 6 - p. e283-e292 , 2017

Link: https://doi.org/10.1016/..

12

Modified CVAD and modified CBAD compared to high‐dose cyclo..:

Gettys, Suzanne C. ; Gulbis, Alison ; Wilhelm, Kaci...
European Journal of Haematology. 98 (2017) 4 - p. 388-392 , 2017

Link: https://doi.org/10.1111/..

13

Double epigenetic modulation of high‐dose chemotherapy with..:

Nieto, Yago ; Valdez, Benigno C. ; Thall, Peter F....
Cancer. 122 (2016) 17 - p. 2680-2688 , 2016

Link: https://doi.org/10.1002/..

14

Levofloxacin Versus Cefpodoxime for Antibacterial Prophylax..:

Doan, Vi Phuong ; Gulbis, Alison ; Yeh, Jason..
Biology of Blood and Marrow Transplantation. 21 (2015) 2 - p. S367-S368 , 2015

Link: https://doi.org/10.1016/..

15

Vorinostat Combined with High-Dose Gemcitabine, Busulfan, a..:

Nieto, Yago ; Valdez, Benigno C. ; Thall, Peter F....
Biology of Blood and Marrow Transplantation. 21 (2015) 11 - p. 1914-1920 , 2015

Link: https://doi.org/10.1016/..